Amanda Nuckols, APRN
Nurse Practitioner · Sylvania, OHNPI 1801360086
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $660 and has fallen 86.8% since, to $87 in 2025. Among nurse practitioner clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $33.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$264
- Seagen Inc.$242
- AstraZeneca$210
- Amgen$162
- Novartis$138
- Sobi, Inc$127
- plus $842 from 19 others
What the payments were for
- Food & beverage$1,87695%
- Education$1085%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $264 |
| Seagen Inc. | 4 | $242 |
| AstraZeneca | 5 | $210 |
| Amgen | 3 | $162 |
| Novartis | 7 | $138 |
| Sobi, Inc | 2 | $127 |
| Novo Nordisk | 2 | $118 |
| GSK | 2 | $112 |
| Johnson & Johnson(2 entities) | 3 | $101 |
| E.r. Squibb & Sons, L.L.C. | 2 | $93 |
| Daiichi Sankyo Inc. | 3 | $55 |
| Beigene USA, Inc. | 1 | $49 |
| Bayer | 3 | $49 |
| Jazz Pharmaceuticals Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $33 |
| Boston Scientific | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Incyte Corporation | 1 | $24 |
| G1 Therapeutics, Inc. | 1 | $22 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $20 |
| Davol Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $15 |
| Taiho Oncology, Inc. | 1 | $14 |
| Bristol Myers Squibb | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,984 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Sylvania
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
- Amy HazelCanton$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.